Renaissance Technologies
PAVM icon

Renaissance Technologies’s PAVmed PAVM Stock Holding History

Renaissance Technologies’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-699
Closed -$415K – 4475
2022
Q1 		$415K Sell
699
-1,361
-66% -$1.01M ﹤0.01% 3300
2021
Q4 		$2.28M Buy
+2,060
New +$4.48M ﹤0.01% 2039
2019
Q1 		– Sell
-23
Closed -$10K – 3629
2018
Q4 		$10K Sell
23
-77
-77% -$37.7K ﹤0.01% 3335
2018
Q3 		$58K Buy
+100
New +$61K ﹤0.01% 3274

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's PAVM Position: Q2 2022 in Review

Renaissance Technologies sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 699 shares — an estimated $415K sold.

Renaissance Technologies first reported a position in PAVM in Q3 2018 and held it in 4 quarters. The position peaked at $2.28M in Q4 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • Renaissance Technologies reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • Renaissance Technologies sold 699 PAVmed shares in Q2 2022, an estimated $415K.
  • Renaissance Technologies first reported a position in PAVmed in Q3 2018 and held it in 4 quarters.
  • Renaissance Technologies's PAVmed position peaked at $2.28M in Q4 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.